What information could the main actors of liquid biopsy provide? —a representative case of non-small cell lung cancer (NSCLC)

In non-small cell lung cancer (NSCLC), there is a consensus regarding the use of liquid biopsy, generally, to detect “druggable” mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI) treatments. However, whether circulating tumor cells (CTCs) are better tools than cell-free DNA (c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Dis
Hlavní autoři: Pezzuto, Aldo, Manicone, Mariangela, Scaini, Maria Chiara, Ricci, Alberto, Mariotta, Salvatore, Zamarchi, Rita, Rossi, Elisabetta
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2018
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6105979/
https://ncbi.nlm.nih.gov/pubmed/30174936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.06.38
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky